comparable to open approach. [7] RPN established its niche as minimally invasive approach to treat SRM since pure laparoscopic approach has been difficult to adopt due to its long, steep learning curve. [7] The da Vinci ® robotic surgical system improves the dexterity, increases visualization, and filters the tremor of the operating surgeon. It also enhances ergonomic setting to boost the surgeon's personal comfort. [8] The adoption of the robotic technique in NSS increased, leading to growth in experience with RPN to treat SRM. [7, 8] The technique and both functional and oncologic outcome of RPN were replicated by multiple authors from different centers. [9, 10] The 5-year cancer-free survival after robotic, laparoscopic, and open NSS for malignant renal masses was reported to be around 91%. [11] RPN was adopted in our institute since September 2009 as the treatment of choice for SRM. In this article, our aim is to report on the oncologic outcome and describe the recurrence pattern of RCC in patients with RCC-treated RPN at our institute.
PATIENTS AND METHODS
We reviewed, with IRB approval, prospectively collected data of the patients who underwent RPN for solid and cystic renal mass. We studied the medical record of patients with final diagnosis of any variant of RCC to identify patients who had recurrence of the disease. From September 2009 to March 2018, RPN was utilized routinely to treat patients with SRM (<4 cm) and selectively in the treatment in larger mass (4-7 cm) at our institute. The indication for RPN was either enhancing solid renal mass, or cystic renal mass classified as Bosniak IIF, III or IV. [12] RENAL nephrometry, first described by Kutikov and Uzzo, was used to guide our decision to perform partial nephrectomy. The score is built on five anatomical features of the renal mass [ Table 1 ]. Four out of the five components are scored on a 1, 2, or 3. The fifth indicates whether the tumor is anterior or posterior. [13] RPN was done transperitoneally with mobilization of the colon medially. The renal hilum was isolated, and the tumor was exposed and then resected under variable warm ischemia time (WIT) ranging from 0 to 34 min. Off-clamp RPN was adopted in certain cases with the technique described by Lamoshi and Salkini. [14] Tumor resection was achieved according to the standard technique. [15] Hilar clamping, when utilized, was achieved using bulldog clamps or laparoscopic Satinsky clamp according to the situation and complexity of the hilum. After the resection, the tumor was placed in all the cases in Endo Catch™ specimen pouch. Renorrhaphy was initially performed according to the standard technique. [15] However, we modified the technique by eliminating the closure of the collecting system and that shortened the WIT in the last 225 cases utilizing the technique described by Williams et al. [16] All specimens were analyzed by dedicated uropathologists. The Fuhrman Grade (FG) was utilized for grading of the tumors. [2, 3] A positive surgical margin (PSM) was defined as the extension of tumor to the inked surface of the resected specimen on the final microscopic pathologic evaluation. Every patient was admitted to the hospital after surgery for a minimum of 24 h and had continuous vital sign monitoring during the first 2-h stay. They also had laboratory testing of basic metabolic panel and complete blood count. All patients were followed using computed tomography scan or magnetic resonance imaging of the abdomen and pelvis with contrast media. The first surveillance imaging was performed 6 months after surgery and at variable period according to the risk of recurrence.
RESULTS
We studied 269 (81%) patients with a final diagnosis of RCC out of the 335 patients who underwent RPN at our institute. The mean age of the patients was 67 years (ranging from 28 to 81), and 183 were male (58%) as in Table 2 .
The mean RENAL nephrometry score for the resected masses was 6.4 (ranging from 4 to 10). The pathological distribution of the tumors was as follows: 192 (71%) patients had clear cell RCC, 50 (19%) patients had papillary RCC, 16 (6%) patients had chromophobe RCC, and 11 (4%) patients had unclassified RCC. Forty-five (17%) patients had FG 1 tumor, 187 (70%) patients had Grade 2 tumors, and 37 (14%) patients had Grade 3 tumors. None of the patients had Grade 4 tumors. The tumors were distributed into 215 (80%) T1a, 42 (16%) T1b, and 12 (4%) T3a. Tumor characteristics are displayed in Table 3 . [15] In fact, the feasibility and safety of the technique have been demonstrated by many authors. [15, 16] It was proven that the required skills for robotic approach may be gained faster than what is needed in the classical laparoscopic skills. [17, 18] [19] However, most of the other studies were unable to show any oncologic difference. [10, 18] We were able to demonstrate comparable oncologic outcome to what has been published in the literature about RPN. [10, 18, 19] The recurrence rate was 2.9% in our study with statistically acceptable sample laparoscopic partial nephrectomy. [22] However, we found both types of recurrences in different patients. The etiology of TSR is likely to be multifactorial, involving tumor biology, local wound and general host immune processes, gas ambiance, and surgical factors. Similar factors are likely to be involved in the etiology of intraperitoneal dissemination, which can occur during both laparoscopic and open surgery. [20] [21] [22] In fact, Song et al. reported for the first TSR involving the camera trocar in robotic surgery after partial nephrectomy. [23] We reported in our series two cases. The first case of TSR was involving the robotic 8-mm metal trocar and the second was involving the assistant trocar. Interestingly, our second case presented 7 years after the surgery. None of the TSR was the camera trocar or tumor excision site. The risk of locoregional recurrence after laparoscopic and open surgery is well known in cancer literature, and it is well reported in Gynecology and Surgical Oncology. [24] Our findings showed that high grade, larger tumor, and papillary types are the surrogate with recurrence. This was compatible with what has been reported in the literature. [11, [20] [21] [22] [23] We found only two cases of recurrence at the resection bed, and that echoes what has been published in the literature. [11] Positive resection margin, tumor violation during surgery was not associated with recurrence, contrary to what has been reported by Petros et al. in their large group long-term follow-up. [25] We had low number of PSM making it difficult to draw statistical conclusion. This study represents one large single center and surgeon experience with RPN, with acceptable length of follow-up. We still recommend longer follow-up and encourage more reporting on the outcome of RPN.
CONCLUSION
RPN yielded low rate of RCC recurrence at our institute. Tumors with Fuhrman histologic Grade ≥3, larger tumors ≥4 cm, and tumors with local invasion T3 tumors are more likely to recur. Papillary type RCC was found to be surrogate with recurrence. Positive margin and violation of the tumor during resection did not translate into recurrence in our series. Tumor Grade  G2  G3  G2  G3  G2  G2  G3  G2  Tumor  T1a  T1b  T3a  T1a  T1b  T1a  T3a  T1b  Timing of the recurrence (months) 18  20  20  24  30  36  36  72  Location of the recurrence  Trocar site Regional Tumor  bed   Tumor  bed   Second primary Second primary Tumor  bed   Trocar site   Age  80  56  64  72  65  75  69  68  Sex  male  male  female  male  female  male  female  female size of 269. The tumor variants, stage, and grade was found to be similar to what has been published in the literature. [10, 18, 19] We, in this study, report on a single-center solo surgeon (MWS) experience with RPN in the treatment of RCC. That, in fact, enabled us to avoid variability in technique and instrumentation and account for the learning curve. However, it makes it fall into the trap of reporting and selection bias. We had a similar period of follow-up compared to other RPN series with almost similar rate of recurrence when compared to other studies as eight patients developed recurrence out of 269 patients with RCC treated with RPN (2.9%). Peyronnet et al. reported a recurrence rate of 5.5% in his multi-institutional data. [19] The main difference is that our data are derived from single-surgeon performance that may explain the lower rate of positive margin and recurrence. Cleveland clinic group reported 11% of recurrence in their hybrid cases of robotic, laparoscopic, and open partial nephrectomy. [11] In this study, we described neglected pattern of RCC recurrence after RPN, that is, TSR with an incidence rate of 0.7%. TSR is underreported in both RPN and laparoscopic partial nephrectomy. We found few reports of TSR in laparoscopic radical nephrectomy and hand-assisted laparoscopic radical nephrectomy. [20, 21] In 2008, Masterson and Russo from Memorial Sloan Kettering Cancer Center reported on a case of combined locoregional and trocar site seeding after
